SE7712693L - Organiska foreningar - Google Patents

Organiska foreningar

Info

Publication number
SE7712693L
SE7712693L SE7712693A SE7712693A SE7712693L SE 7712693 L SE7712693 L SE 7712693L SE 7712693 A SE7712693 A SE 7712693A SE 7712693 A SE7712693 A SE 7712693A SE 7712693 L SE7712693 L SE 7712693L
Authority
SE
Sweden
Prior art keywords
hydrogen
nasal
methoxy
isopropyl
methyl
Prior art date
Application number
SE7712693A
Other languages
Unknown language ( )
English (en)
Other versions
SE451944B (sv
Inventor
M Azria
T Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7712693L publication Critical patent/SE7712693L/sv
Publication of SE451944B publication Critical patent/SE451944B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2207/00—Indexing scheme relating to details of indicating measuring values
    • G01D2207/10—Displays which are primarily used in aircraft or display aircraft-specific information

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7712693A 1976-11-19 1977-11-10 Sett att framstella en dihydroergotamin-beredningsform med hog resorption SE451944B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1457576 1976-11-19
CH698977 1977-06-07

Publications (2)

Publication Number Publication Date
SE7712693L true SE7712693L (sv) 1978-05-20
SE451944B SE451944B (sv) 1987-11-09

Family

ID=25700540

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7712693A SE451944B (sv) 1976-11-19 1977-11-10 Sett att framstella en dihydroergotamin-beredningsform med hog resorption

Country Status (27)

Country Link
US (2) US4462983A (sv)
JP (1) JPS5366440A (sv)
AT (1) AT368881B (sv)
AU (1) AU520754B2 (sv)
CA (1) CA1103585A (sv)
CS (2) CS228502B2 (sv)
CY (1) CY1266A (sv)
DE (2) DE2750090A1 (sv)
DK (1) DK153440C (sv)
ES (1) ES464275A1 (sv)
FI (1) FI773376A (sv)
FR (1) FR2371454A1 (sv)
GB (1) GB1592563A (sv)
GR (1) GR65229B (sv)
HK (1) HK85984A (sv)
HU (1) HU185924B (sv)
IE (1) IE46167B1 (sv)
IL (1) IL53419A (sv)
KE (1) KE3453A (sv)
MY (1) MY8400055A (sv)
NL (1) NL187892C (sv)
NO (1) NO773839L (sv)
NZ (1) NZ185711A (sv)
PH (1) PH23643A (sv)
PT (1) PT67292B (sv)
SE (1) SE451944B (sv)
SG (1) SG61784G (sv)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
FI81258C (sv) * 1982-02-01 1990-10-10 Sandoz Ag Förfarande för framställning av en farmaceutisk komposition för nasal administration
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
FR2628638B1 (fr) * 1985-03-06 1992-12-18 Sandoz Lab Dispositif de pulverisation par voie nasale d'une dose unitaire de medicament en solution
JPS61263918A (ja) * 1985-05-16 1986-11-21 Banyu Pharmaceut Co Ltd 経皮吸収用製剤
WO1986006959A1 (en) * 1985-05-22 1986-12-04 Liposome Technology, Inc. Liposome inhalation method and system
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
EP0338670B1 (en) * 1988-03-22 1994-05-11 FISONS plc Pharmaceutical Compositions
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
EP0606486B1 (en) * 1992-06-12 2001-08-29 Teijin Limited Pharmaceutical preparation for intra-airway administration
ATE222754T1 (de) * 1992-06-12 2002-09-15 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
US6794357B1 (en) * 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
WO1996019206A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Therapeutic preparation for inhalation containing parathyroïd hormone, pth
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
BR0107764A (pt) * 2000-01-20 2002-11-12 Basilea Pharmaceutica Ag Composições de peptìdeo cìclico nasalmente administráveis
US20030008005A1 (en) * 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB2405334B (en) * 2002-04-17 2006-02-15 Nektar Therapeutics Uk Ltd Particulate materials
ES2538082T3 (es) * 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
US20120000941A1 (en) * 2010-06-30 2012-01-05 Inspire Pharmaceuticals, Inc. Medicine dispenser
WO2017044897A1 (en) 2015-09-10 2017-03-16 Impel Neuropharma Inc. In-line nasal delivery device
EP3648738A1 (en) * 2017-07-02 2020-05-13 Dr. Reddy's Laboratories Limited Nasal dosage forms of dihydroergotamine
EP4147699A1 (en) 2018-01-05 2023-03-15 Impel Pharmaceuticals Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
GB2581431A (en) * 2018-12-11 2020-08-19 Satsuma Pharmaceuticals Inc Compositions, devices, and methods for treating or preventing headaches
WO2020123607A1 (en) 2018-12-11 2020-06-18 Satsuma Pharmaceuticals, Inc. Compositions, devices, and methods for treating or preventing headaches

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US4076715A (en) * 1972-09-26 1978-02-28 Sandoz Ltd. 13-Bromo lysergic acid compounds
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
NL7314066A (sv) * 1972-10-18 1974-04-22
US3896228A (en) * 1973-03-15 1975-07-22 Sandoz Ltd Method for treating nephrises
US3883655A (en) * 1973-10-11 1975-05-13 Sandoz Ltd Ergocornine or 2-bromo-{60 -ergocyptine in the treatment of parkinsonism
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
EP0119493A1 (en) * 1983-03-16 1984-09-26 American Cyanamid Company Use of copolymers of 2-acrylamido-2-methylpropane sulfonic acid for improving retention and dewatering in the manufacture of paper

Also Published As

Publication number Publication date
AU520754B2 (en) 1982-02-25
HK85984A (en) 1984-11-16
MY8400055A (en) 1984-12-31
NO773839L (no) 1978-05-22
NL187892C (nl) 1992-02-17
PT67292A (fr) 1977-12-01
IL53419A0 (en) 1978-01-31
NL7712552A (nl) 1978-05-23
NZ185711A (en) 1980-04-28
ES464275A1 (es) 1978-12-16
DK153440B (da) 1988-07-18
CS228502B2 (en) 1984-04-16
AU3078377A (en) 1979-05-24
CY1266A (en) 1984-11-23
CA1103585A (en) 1981-06-23
IE46167L (en) 1978-05-19
HU185924B (en) 1985-03-28
JPS5366440A (en) 1978-06-13
US4462983A (en) 1984-07-31
JPS6313965B2 (sv) 1988-03-29
FR2371454A1 (fr) 1978-06-16
SG61784G (en) 1985-03-15
ATA825477A (de) 1982-04-15
SE451944B (sv) 1987-11-09
US4758423A (en) 1988-07-19
FR2371454B1 (sv) 1980-08-22
AT368881B (de) 1982-11-25
GR65229B (en) 1980-07-30
GB1592563A (en) 1981-07-08
DE2802113A1 (de) 1979-07-26
NL187892B (nl) 1991-09-16
PH23643A (en) 1989-09-27
FI773376A (fi) 1978-05-20
IL53419A (en) 1982-04-30
DK153440C (da) 1989-01-02
CS228523B2 (en) 1984-05-14
IE46167B1 (en) 1983-03-09
DE2750090A1 (de) 1978-06-01
PT67292B (fr) 1979-11-12
DK499477A (da) 1978-05-20
KE3453A (en) 1984-10-05

Similar Documents

Publication Publication Date Title
SE7712693L (sv) Organiska foreningar
FI802173A (fi) Terapeutiskt aktiva substituerade piperidiner och pyrrolidiner
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
SE7714592L (sv) Cyklopentan-1-aminer, forfarande for framstellning derav och medel innehallande dessa foreningar
NO149888C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-substituerte-2`-hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
ES8306142A1 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
NO800447L (no) Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser
NO891949L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser.
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
NO163736C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoxy-substituerte beta-carbolin-derivater.
SE8107524L (sv) Heterocykliska foreningar
GB1494560A (en) 4-aryl-5-aminoalkyl-4-thiazolin-2-ones and their preparation
GB2006196A (en) Phenylacetamides with analgesic activity
AU564739B2 (en) Acridanone derivatives
DE3772850D1 (de) Thiadiazinon-derivate.
SE8303718L (sv) E-homo-enurnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
SE8002001L (sv) Isoindolinderivat, forfarande for framstellning derav och terapeutiska kompositioner som innehaller derivatet
NO833978L (no) Fremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater
ATE36536T1 (de) Phosphoroimidate.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7712693-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7712693-6

Format of ref document f/p: F